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Infection of CD4/ T-lymphoblastoid cells by cytopathic strains of HIV-1 results in an increase in cell volume that leads
to lysis and cell death. The increase in volume is attributable in part to an HIV-induced increase in intracellular monovalent
ion concentrations mediated by the plasma membrane-associated Na//K//2 Cl0 cotransporter. Loop diuretics, which inhibit
cotransporter activity, blocked HIV-induced HIV production and cytopathic effects at physiologically employed concentra-
tions. q 1996 Academic Press, Inc.
The primary feature of HIV pathogenesis is a severe cells increases beyond the limits of the plasma mem-
brane’s ability to maintain integrity (13, 22, 29). Ultrastruc-and progressive depletion of CD4/ T-lymphocytes (22).
Several lines of evidence indicate that direct cytopathol- tural analysis (10) and studies with ultraviolet light-inacti-
vated HIV-1 (29, 37 ) suggest that perturbation of theogy mediated by HIV contributes to CD4/ T-cell depletion
in AIDS patients. Infection of cultured cells bearing CD4, plasma membrane is an early event that contributes to
cell killing by HIV. Previously we had shown that infectionwhich serves as the surface receptor for HIV, results in
cytopathic effects (CPE), but cells lacking CD4 are gener- by HIV increases the intracellular concentrations of both
Na/ and K/ ([Na/]i and [K
/]i), the major monovalent cat-ally spared HIV-induced CPE. HIV variants with increased
cytopathic potential are the dominant types that emerge ions in eukaryotic cells (38). Cytopathic strains of HIV
increased [Na/]i and [K
/]i to a greater extent than HIVduring progression to the late stages of HIV disease (7,
9). Recent studies suggesting that HIV production and strains with lower cytopathic potential. The increases in
intracellular monovalent cation concentrations tempo-turnover of CD4/ cells occur at a significantly higher rate
than previously suspected and that increases in virus pro- rally correlated with cell volume increases observed dur-
ing the development of HIV-induced cytopathology. Ionsduction correlate with accelerated loss of CD4/ T-cells
further support the concept that direct HIV-mediated cyto- are the most abundant osmotically active species in eu-
karyotic cells, and increases in ion content mediated bypathology contributes to depletion of CD4/ T-cells in AIDS
(20, 40). Direct cytotoxicity of HIV or virion components HIV would be expected to increase cell volume (30).
The osmotic cell swelling induced by HIV could providemay also contribute to other aspects of AIDS pathogene-
sis including neurological dysfunctions (13, 18). the motive force for the membrane separation and cy-
toskeletal disruption that may be required to form multi-Many viruses, including HIV, induce alterations of
plasma membrane function in the course of cytolytic in- nucleated cells and could account for the ballooning de-
generation of HIV-induced syncytial cells (3, 13, 21, 28).fection. Cell–cell fusion in which infected and uninfected
cells form syncytia or multinucleated giant cells is among Volume alterations may also contribute to death of single
cells that do not undergo cell–cell fusion, since it ap-the cytopathic effects mediated by HIV (10, 12, 13). HIV-
induced cytopathology also results in death of single pears that cell swelling induced by HIV is irreversible in
the majority of infected cells (12, 13). Single cells that docells (32). Both syncytial and single cells undergo ‘‘bal-
looning degeneration’’ in which the volume of the infected not undergo swelling or are able to compensate for the
HIV-induced alterations in cell volume may survive to
form chronically infected cells.
1 Present address: Department of Internal Medicine, Division of Infec- The Na//K//2Cl0 cotransporter is an integral mem-
tious Diseases, University Hospital, Rdmistrasse 100, CH-8304 Zurich,
brane protein that functions as a major volume regulatorSwitzerland.
in eukaryotic cells by mediating Na/, K/, and Cl0 fluxes2 To whom correspondence and reprint requests should be ad-
dressed. Fax: (504) 588-5144. E-mail: rgarry@tmcpop.tmc.tulane.edu. (11, 23, 24, 33, 36). Originally defined as ‘‘ouabain-insensi-
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FIG. 1. Inhibition of HIV-mediated cytopathology by an inhibitor of the Na//K//2 Cl0 cotransporter. RH9 T-lymphoblastoid cells were infected with
HIV-1LAI at a m.o.i. of 10 and then exposed to medium containing various concentrations between 10 mM and 1 mM of furosemide, a loop diuretic
that is a specific inhibitor of the Na//K//2 Cl0 cotransporter. After 48 hr cells were examined by light microscopy. (A) No drug; (B) 10 mM furosemide;
(C) 100 mM furosemide; (D) 1 mM furosemide.
tive Na/ and K/ leakage,’’ it was identified only after pathology may be attributable to an increase in ion trans-
port mediated by the diuretic-sensitive Na//K//2Cl0 co-development of 5-sulfamoyl benzoic acid drugs (loop di-
uretics, e.g., furosemide and bumetanide) that affect cell transporter.
To examine the role of the increase in activity of thevolume and specifically inhibit cotransporter function by
direct binding (35). Previous studies have shown that Na//K//2Cl0 cotransporter in HIV-mediated cytopathol-
ogy, RH9 cells, an established line of CD4/ T-lymph-uninfected T-lymphoblastoid cells exhibit low levels of
Na//K//2Cl0 cotransporter activity (13, 17, 38). This result oblastoid cells, were infected with HIV-1 strain LAI (HIV-
1LAI ; formerly IIIB) and then incubated in medium (RPMI-is expected because these cells are not undergoing large
shifts in cell volume. However, T-cells acutely infected 1640 plus 10% Serum Plus, JRH Biosciences, Lenexa, KS)
containing furosemide, a loop diuretic that is a specificby HIV demonstrated a marked increase in activity of the
Na//K//2Cl0 cotransporter at times after infection when inhibitor of Na//K//2Cl0 cotransporter, at concentrations
of 0, 10 mM, 100 mM, and 1 mM. By 48 hr postinfectionCPE was evident in the cultures in the form of ballooning
syncytial and single cells. Preliminary studies indicated non-drug-treated cells demonstrated CPE, single cell bal-
looning, and syncytium formation, typical of this cyto-that the increase in Na//K//2Cl0 cotransporter activity
appeared to be due to an increase in the number of pathic strain of HIV (Fig. 1A). Cells treated with 10 and
100 mM furosemide, concentrations that inhibit the co-functional cotransporters, rather than activation of ex-
isting cotransporters (Voss et al., unpublished observa- transporter, showed markedly reduced syncytium forma-
tion and single cell killing (Figs. 1B and 1C). The majoritytions). In contrast, cells that survived the acute cytopathic
effects of HIV to form persistently infected cultures dis- of HIV-infected cells treated with these concentrations
of furosemide were able to survive acute infection fromplayed low levels of Na//K//2Cl0 cotransporter activity
(R.F.G., unpublished observations). These results sug- 2 to 4 weeks longer than untreated cells. Cells treated
with 1 mM furosemide also demonstrated reduced CPEgest that the ballooning degeneration of multinucleated
and single infected cells undergoing HIV-mediated cyto- (Fig. 1D). However, cells treated with this saturating drug
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size) and washed and analyzed using a Fluorescence
Concentration Analyzer (Idexx Laboratories, Westbrook,
ME). The FCA allows rapid semiautomated washing of
suspension cells in physiological buffers (pH 7.2) by use
of a vacuum manifold and quantitation of fluorescence
intensity. The pore-forming ionophores valinomycin (5
mM ) (for PBFI) or gramicidin (5 mM ) (for Sodium Green)
that allow equilibration between extracellular and intra-
cellular ion concentrations and buffers containing vari-
ous concentrations of KCl or NaCO3 were used to pro-
duce a standard curve for [K/]i and [Na
/]i .
The results of the fluorescence concentration analysis
confirmed previous studies (13, 17, 38) indicating that
acute cytopathic infection by HIV increases both [Na/]i
and [K/]i (Fig. 2). Inhibition of cotransporter activity by
bumetanide reduced both [Na/]i and [K
/]i of HIV-infected
FIG. 2. Effect of an inhibitor of the Na//K//2Cl0 cotransporter on cells. At 48 hr after HIV infection, non-drug-treated RH9
intracellular Na/ and K/ concentrations. RH9 T-lymphoblastoid cells cells had an [Na/]i of approximately 105 mM. HIV-in-
were infected with HIV-1LAI at a m.o.i. of 10 and then exposed to medium fected cells treated with either 10 or 100 mM bumetanide
containing 0, 10, or 100 mM bumetanide, a loop diuretic. Measurements
displayed [Na/]i in the range of 10–13 mM which isof [Na/]i and [K/]i were performed in diuretic-treated HIV-infected cells
comparable to [Na/]i of uninfected cells. K
/ measure-at 48 hr postinfection by fluorescence concentration analysis with the
potassium indicator PBFI or the sodium indicator Sodium Green. Data ments indicated that bumetanide reduced the [K/]i in
represent the mean { the standard error of the mean (SEM) of three HIV-infected cells from approximately 500 to 290–310
separate determinations. mM (Fig. 2). Although this [K/]i is not at normal physiolog-
ical levels (125–140 mM ), the altered level may not have
been sufficient to induce HIV cytopathology. The resultsconcentration did not show extended survival because
of drug toxicity. Bumetanide, a loop diuretic related to
furosemide, also inhibited HIV-induced CPE (data not
shown). Bumetanide has a higher affinity for the Na//K//
2Cl0 cotransporter (36) and blocked HIV-induced CPE at
5- to 10-fold lower concentrations than furosemide.
These results suggest that increased activity of the Na//
K//2Cl0 cotransporter plays a role in the development
of HIV-specific CPE and that inhibition of cotransporter
activity can reduce HIV-mediated cell cytopathology in
cultured CD4/ T-lymphoblastoid cells.
To confirm that inhibition of HIV-induced CPE by loop
diuretics could be attributed to effects of these drugs on
ion transport, [Na/]i and [K
/]i were measured in diuretic-
treated HIV-infected cells. The fluorescent ion probes
potassium-binding benzofuran isophthalate acetoxy-
methyl ester (PBFI-AM) and Sodium Green tetraacetate
acetoxymethyl ester (Sodium Green-AM) were used to
quantitate [Na/]i and [K
/]i by previously described meth-
ods (38). PBFI-AM and Sodium Green-AM are retained
in cells after cleavage of the acetoxymethyl group by
endogenous esterases and bind their respective target
ions in a one to one ratio. These dyes display large shifts
in fluorescence emission spectra after stochiometric
binding of K/ and Na/ and have been employed exten-
FIG. 3. Inhibition of HIV production by an inhibitor of the Na//K//sively to quantitate concentrations of these ions in viable
2Cl0 cotransporter. RH9 T-lymphoblastoid cells were infected with HIV-cells (34 ). RH9 cells were infected with HIV-1LAI (m.o.i. of
1LAI at a m.o.i. of 10, washed, and then exposed to medium containingapproximately 10) or mock-infected and then loaded with
various concentrations of bumetanide. After a week, cells and superna-
PBFI or Sodium Green at 48 hr after infection. Cells were tants were harvested and the amounts of p24 antigen quantitated by
plated into a 96-well Fluoricon GF assay plate (50,000 HIV antigen capture enzyme-linked immunoassay (Abbott Labora-
tories). Data represent the mean { SEM of three determinations.cells per well) fitted with a glass fiber filter (1.0-mm pore
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